COVID-19

Views & Analysis

Pharma’s response to COVID: GSK

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future.

News

Government needs strategy to kick-start R&D after COVID, say...

The UK has been leading research into the COVID-19 outbreak, according to the country’s pharma trade body, but there needs to be a strategy to restart trials into other diseases.

News

Roche working “around the clock” to tackle UK test supply pr...

Supplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease have been threatened by a failure at a facility operated by Roche.

News

GSK and Vir expand COVID-19 antibody trial after Trump's tre...

GlaxoSmithKline and partner Vir Biotechnology are to expand a trial of an experimental antibody to treat COVID-19, putting heat on Regeneron’s rival that has been famously used to treat pre

News

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

The FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Trump administration, but it has still managed to make its new approach pub

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Race for COVID-19 vaccine hots up as EMA begins review of Bi...

The European Medicines Agency has begun a second “rolling review” of a potential coronavirus vaccine jointly developed by BioNTech and Pfizer, setting up a race with a rival from AstraZenec

Pharma’s response to COVID: GSK

Government needs strategy to kick-start R&D after COVID, say...

Roche working “around the clock” to tackle UK test supply pr...

GSK and Vir expand COVID-19 antibody trial after Trump's tre...

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

Race for COVID-19 vaccine hots up as EMA begins review of Bi...

GSK planning 1,200 job cuts in Belgium, says paper

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks